Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Oncoimmunology|May 4, 2018
High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusionVerena Nilius, Madeleine C Killer, Nina Timmesfeld, et al.
Leukemia Research|October 7, 2017
Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemiaKatharina Henkenius, Brandon H Greene, Christina Barckhausen, et al.
Cytotherapy|December 3, 2014
Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiationPhilipp Nold, Holger Hackstein, Tabea Riedlinger, et al.
Journal of Nanobiotechnology|September 19, 2019
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCsPhilipp Nold, Raimo Hartmann, Neus Feliu, et al.
Journal of Nanobiotechnology|March 31, 2017
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCsPhilipp Nold, Raimo Hartmann, Neus Feliu, et al.
Blood|October 24, 2002
Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemiaAndreas Burchert, Stefan Wölfl, Manuel Schmidt, et al.
Human Mutation|April 18, 2012
Molecular and biochemical characterization of a unique mutation in CCS, the human copper chaperone to superoxide dismutasePeter Huppke, Cornelia Brendel, Georg Christoph Korenke, et al.
Cancer Research|September 1, 2018
Development, Function, and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid LeukemiaSabrina Inselmann, Ying Wang, Susanne Saussele, et al.
Haematologica|November 3, 2009
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationMartin Bornhäuser, Uta Oelschlaegel, Uwe Platzbecker, et al.
Leukemia & Lymphoma|January 16, 2019
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantationDeborah Christen, Kristina Sohlbach, Stephan K Metzelder, et al.
Pageof 7